ADNI | Publications

×

×

Select the area you would like to search.
ADNI SITE
DATA DICTIONARY This search queries the ADNI data dictionary. Enter terms or codes used in the dictionary for a definition, or enter search terms to locate data within the archive.
ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.

Publications

ADNI publication pdfs can be searched by author, keyword, or
PMCID using the ADNI PDF search above.

Filter results by:

1800 Total Publications

Diagnostic accuracy of markers for prodromal Alzheimer’s disease in independent clinical series.
Prestia, A., Caroli, A., Herholz, K., Reiman, E., Chen, K., Jagust, W. J., & Frisoni, G. B.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 6; pp. 677-86; AWUVFUjTMOwVf_qbJr8M doi:10.1016/j.jalz.2012.09.016

Effect of cognitive reserve markers on Alzheimer pathologic progression.
Lo, R. Y., & Jagust, W. J.
2013; Journal Alzheimer's Disease and Associated Disorders; vol. 27; pp. 343-350; AWUVFUjTMOwVf_qbJr8P doi:10.1097/WAD.0b013e3182900b2b

Improving the convergence rate in affine registration of PET and SPECT brain images using histogram equalization.
Salas-Gonzalez, D., Górriz, J. M., Ramírez, J., Padilla, P., & Illán, I. A.
2013; Journal Computational and Mathematical Methods in Medicine; vol. 760903; AWUVFUjTMOwVf_qbJr8S doi:10.1155/2013/760903

Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease.
Guo, L.-H., Alexopoulos, P., & Perneczky, R.
2013; Journal European Archives of Psychiatry and Clinical Neuroscience; vol. 263; no. 7; pp. 553-60; AWUVFUjTMOwVf_qbJr8T doi:10.1007/s00406-013-0405-4

Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
Shokouhi, S., Claassen, D., Kang, H., Ding, Z., Rogers, B., Mishra, A., & Riddle, W. R.
2013; Journal Journal of Nuclear Medicine; vol. 54; no. 9; pp. 1564-9; AWUVFUjTMOwVf_qbJr8e doi:10.2967/jnumed.112.116137

Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50; AWUVFUjTMOwVf_qbJr8i doi:10.1038/nature12415

Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94; AWUVFUjTMOwVf_qbJr8n doi:10.1016/j.nicl.2013.07.005

Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer’s disease.
Mattsson, N., Insel, P., Tosun, D., Zhang, J., Jack Jr., C. R., Galasko, D., … Weiner, M.
2013; Journal PloS One; vol. 8; no. 12; pp. e85443; AWUVFUjTMOwVf_qbJr8s doi:10.1371/journal.pone.0085443

STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation.
Jorge Cardoso, M., Leung, K., Modat, M., Keihaninejad, S., Cash, D., Barnes, J., … Ourselin, S.
2013; Journal Medical Image Analysis; vol. 17; no. 6; pp. 671-84; AWUVGYvTMOwVf_qbJr8w doi:10.1016/j.media.2013.02.006

Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50; AWUVGYvTMOwVf_qbJr8x doi:10.1038/nature12415